Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

The hair follicle dermal sheath is essential for hair shedding and needs to communicate with the outer root sheath for normal hair growth cycles.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Surgery resolved hormone imbalance and symptoms in a rare ovarian tumor case in an elderly woman.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Gender affirming hormone therapy improves outcomes in gender affirmation surgery.

Gender and social factors, not just biology, affect COVID-19 death rates.

Patients with androgenetic alopecia have thinner subcutaneous fat layers in their frontal scalp compared to healthy individuals.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

Understanding sex and gender differences can improve personalized dermatology care.

Finger length ratios might predict risk for skin condition in males.

Higher DHT levels are linked to more acne in adolescents, especially boys.

A balanced diet is crucial for normalizing hormone levels and managing obesity-related issues.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

High AMH levels are linked to PCOS in women and may have a male equivalent with similar traits.

Most transgender adolescents continued hormone treatment, with few stopping due to reasons other than returning to their birth gender.

AMH is a promising biomarker for diagnosing PCOS.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Exercise, especially vigorous aerobic and resistance training, can improve hormone levels in women with PCOS.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Prenatal and postnatal environments both affect PCOS development and gut microbiota in mice.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

The HairCheck® device is effective for measuring hair loss and growth in people with alopecia.